{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:28:48Z","timestamp":1772134128978,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873639"],"award-info":[{"award-number":["81873639"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070839"],"award-info":[{"award-number":["82070839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017596","name":"Natural Science Basic Research Program of Shaanxi Province","doi-asserted-by":"publisher","award":["2020JZ-31"],"award-info":[{"award-number":["2020JZ-31"]}],"id":[{"id":"10.13039\/501100017596","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01964-7","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T12:04:16Z","timestamp":1669377856000},"page":"1145-1154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["MicroRNA-137 inhibits pituitary prolactinoma proliferation by targeting AKT2"],"prefix":"10.1007","volume":"46","author":[{"given":"Q.","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. X.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. L.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q. H.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9711-4316","authenticated-orcid":false,"given":"J.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"1964_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2014.11.004","volume":"44","author":"S Melmed","year":"2015","unstructured":"Melmed S (2015) Pituitary tumors. Endocrinol Metab Clin North Am 44:1\u20139. https:\/\/doi.org\/10.1016\/j.ecl.2014.11.004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1964_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11102-011-0348-6","volume":"15","author":"LJ Sheplan Olsen","year":"2012","unstructured":"Sheplan Olsen LJ, Robles Irizarry L, Chao ST et al (2012) Radiotherapy for prolactin-secreting pituitary tumors. Pituitary 15:135\u2013145. https:\/\/doi.org\/10.1007\/s11102-011-0348-6","journal-title":"Pituitary"},{"key":"1964_CR3","volume-title":"WHO classification of tumours of endocrine organs: WHO classification of tumours","author":"RV Lloyd","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kloppel G, Rosai J (2017) WHO classification of tumours of endocrine organs: WHO classification of tumours. International Agency for Research on Cancer, Lyon"},{"key":"1964_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ecl.2020.05.001","volume":"49","author":"MBS Lopes","year":"2020","unstructured":"Lopes MBS (2020) World health ozganization 2017 classification of pituitary tumors. Endocrinol Metab Clin North Am 49:375\u2013386. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1964_CR5","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P et al (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24:C5\u2013C8. https:\/\/doi.org\/10.1530\/ERC-17-0004","journal-title":"Endocr Relat Cancer"},{"key":"1964_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrendo.2011.37","volume":"7","author":"A Colao","year":"2011","unstructured":"Colao A, Savastano S (2011) Medical treatment of prolactinomas. Nat Rev Endocrinol 7:267\u2013278. https:\/\/doi.org\/10.1038\/nrendo.2011.37","journal-title":"Nat Rev Endocrinol"},{"key":"1964_CR7","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1007\/s11064-019-02789-2","volume":"44","author":"L Krokker","year":"2019","unstructured":"Krokker L, Ny\u00edr\u0151 G, Reiniger L et al (2019) Differentially expressed miRNAs influence metabolic processes in pituitary oncocytoma. Neurochem Res 44:2360\u20132371. https:\/\/doi.org\/10.1007\/s11064-019-02789-2","journal-title":"Neurochem Res"},{"key":"1964_CR8","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1158\/1541-7786.MCR-19-0434","volume":"17","author":"N V\u00e4lim\u00e4ki","year":"2019","unstructured":"V\u00e4lim\u00e4ki N, Schalin-J\u00e4ntti C, Karppinen A et al (2019) Genetic and epigenetic characterization of growth hormone-secreting pituitary tumors. Mol Cancer Res 17:2432\u20132443. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0434","journal-title":"Mol Cancer Res"},{"key":"1964_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110520","volume":"496","author":"AD van den Brand","year":"2019","unstructured":"van den Brand AD, Rubinstein E, van den Berg M, van Duursen MBM (2019) GH3 and RC-4BC cell lines are not suitable as in vitro models to study prolactin modulation and AHR responsiveness in rat pituitary. Mol Cell Endocrinol 496:110520. https:\/\/doi.org\/10.1016\/j.mce.2019.110520","journal-title":"Mol Cell Endocrinol"},{"key":"1964_CR10","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1101\/gr.089367.108","volume":"19","author":"I Lee","year":"2009","unstructured":"Lee I, Ajay SS, Yook JI et al (2009) New class of microRNA targets containing simultaneous 5\u2032-UTR and 3\u2032-UTR interaction sites. Genome Res 19:1175\u20131183. https:\/\/doi.org\/10.1101\/gr.089367.108","journal-title":"Genome Res"},{"key":"1964_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nsmb.2296","volume":"19","author":"MR Fabian","year":"2012","unstructured":"Fabian MR, Sonenberg N (2012) The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 19:586\u2013593. https:\/\/doi.org\/10.1038\/nsmb.2296","journal-title":"Nat Struct Mol Biol"},{"key":"1964_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5","journal-title":"Cell"},{"key":"1964_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","volume":"20","author":"T Treiber","year":"2019","unstructured":"Treiber T, Treiber N, Meister G (2019) Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol 20:5\u201320. https:\/\/doi.org\/10.1038\/s41580-018-0059-1","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1964_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019494","volume":"27","author":"MI Qadir","year":"2017","unstructured":"Qadir MI, Faheem A (2017) miRNA: a diagnostic and therapeutic tool for pancreatic cancer. Crit Rev Eukaryot Gene Expr 27:197\u2013204. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2017019494","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"1964_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2174\/138920101505140828161335","volume":"15","author":"Y Tutar","year":"2014","unstructured":"Tutar Y (2014) Editorial (thematic issue: \u201cmiRNA and cancer; computational and experimental approaches\u201d). Curr Pharm Biotechnol 15:429\u2013429. https:\/\/doi.org\/10.2174\/138920101505140828161335","journal-title":"Curr Pharm Biotechnol"},{"key":"1964_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1055\/s-0043-123763","volume":"50","author":"Y Feng","year":"2018","unstructured":"Feng Y, Mao Z, Wang X et al (2018) microRNAs and target genes in pituitary adenomas. Horm Metab Res 50:179\u2013192. https:\/\/doi.org\/10.1055\/s-0043-123763","journal-title":"Horm Metab Res"},{"key":"1964_CR17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1210\/jc.2011-3482","volume":"97","author":"D D\u2019Angelo","year":"2012","unstructured":"D\u2019Angelo D, Palmieri D, Mussnich P et al (2012) Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J Clin Endocrinol Metab 97:1128\u20131138","journal-title":"J Clin Endocrinol Metab"},{"key":"1964_CR18","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru Y, Kechris KJ, Tabakoff B et al (2014) The multiMiR R package and database: integration of microRNA\u2013target interactions along with their disease and drug associations. Nucleic Acids Res 42:e133\u2013e133. https:\/\/doi.org\/10.1093\/nar\/gku631","journal-title":"Nucleic Acids Res"},{"key":"1964_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-022-00860-9","volume":"29","author":"P-J Tsai","year":"2022","unstructured":"Tsai P-J, Lai Y-H, Manne RK et al (2022) Akt: a key transducer in cancer. J Biomed Sci 29:76. https:\/\/doi.org\/10.1186\/s12929-022-00860-9","journal-title":"J Biomed Sci"},{"key":"1964_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG et al (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6:425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","journal-title":"Signal Transduct Target Ther"},{"key":"1964_CR21","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"Barrett T, Wilhite SE, Ledoux P et al (2012) NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res 41:D991\u2013D995. https:\/\/doi.org\/10.1093\/nar\/gks1193","journal-title":"Nucleic Acids Res"},{"key":"1964_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2015.00054","author":"M Roche","year":"2015","unstructured":"Roche M, Wierinckx A, Croze S et al (2015) Deregulation of miR-183 and KIAA0101 in aggressive and malignant pituitary tumors. Front Med. https:\/\/doi.org\/10.3389\/fmed.2015.00054","journal-title":"Front Med"},{"key":"1964_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2011.00476.x","author":"A Wierinckx","year":"2011","unstructured":"Wierinckx A, Roche M, Raverot G et al (2011) Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumors: integrated genomic profiling in PRL pituitary tumors. Brain Pathol. https:\/\/doi.org\/10.1111\/j.1750-3639.2011.00476.x","journal-title":"Brain Pathol"},{"key":"1964_CR24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12859-018-2531-5","volume":"19","author":"T Xu","year":"2018","unstructured":"Xu T, Su N, Liu L et al (2018) miRBaseConverter: an R\/Bioconductor package for converting and retrieving miRNA name, accession, sequence and family information in different versions of miRBase. BMC Bioinform 19:514. https:\/\/doi.org\/10.1186\/s12859-018-2531-5","journal-title":"BMC Bioinform"},{"key":"1964_CR25","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam J-W, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4:e05005. https:\/\/doi.org\/10.7554\/eLife.05005","journal-title":"Elife"},{"key":"1964_CR26","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1261\/rna.5248604","volume":"10","author":"M Rehmsmeier","year":"2004","unstructured":"Rehmsmeier M, Steffen P, H\u00f6chsmann M, Giegerich R (2004) Fast and effective prediction of microRNA\/target duplexes. RNA 10:1507\u20131517. https:\/\/doi.org\/10.1261\/rna.5248604","journal-title":"RNA"},{"key":"1964_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130124","volume":"10","author":"L Wu","year":"2015","unstructured":"Wu L, Chen J, Ding C et al (2015) MicroRNA-137 contributes to dampened tumorigenesis in human gastric cancer by targeting AKT2. PLoS ONE 10:e0130124. https:\/\/doi.org\/10.1371\/journal.pone.0130124","journal-title":"PLoS ONE"},{"key":"1964_CR28","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac010","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB et al (2022) Clinical biology of the pituitary adenoma. Endocr Rev. https:\/\/doi.org\/10.1210\/endrev\/bnac010","journal-title":"Endocr Rev"},{"key":"1964_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1227\/01.NEU.0000349930.66434.82","volume":"65","author":"F Salehi","year":"2009","unstructured":"Salehi F, Agur A, Scheithauer BW et al (2009) KI-67 in pituitary neoplasms. Neurosurgery 65:429\u2013437. https:\/\/doi.org\/10.1227\/01.NEU.0000349930.66434.82","journal-title":"Neurosurgery"},{"key":"1964_CR30","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/eje.0.143r001","volume":"143","author":"S Jordan","year":"2000","unstructured":"Jordan S, Lidhar K, Korbonits M et al (2000) Cyclin D and cyclin E expression in normal and adenomatous pituitary. Eur J Endocrinol 143:R1\u2013R6. https:\/\/doi.org\/10.1530\/eje.0.143r001","journal-title":"Eur J Endocrinol"},{"key":"1964_CR31","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/cancers11101605","volume":"11","author":"MD Ilie","year":"2019","unstructured":"Ilie MD, Vasiljevic A, Raverot G, Bertolino P (2019) The microenvironment of pituitary tumors\u2014biological and therapeutic implications. Cancers 11:1605. https:\/\/doi.org\/10.3390\/cancers11101605","journal-title":"Cancers"},{"issue":"14","key":"1964_CR32","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1101\/gad.215939.113","volume":"27","author":"FV Karginov","year":"2013","unstructured":"Karginov FV, Hannon GJ (2013) Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev 27(14):1624\u20131632. https:\/\/doi.org\/10.1101\/gad.215939.113","journal-title":"Genes Dev"},{"key":"1964_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbrc.2019.09.070","volume":"520","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Wang Z, Hu B et al (2019) MiR-1299 promotes the synthesis and secretion of prolactin by inhibiting FOXO1 expression in drug-resistant prolactinomas. Biochem Biophys Res Commun 520:79\u201385. https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.070","journal-title":"Biochem Biophys Res Commun"},{"key":"1964_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1590\/0004-2730000002961","volume":"58","author":"A Glezer","year":"2014","unstructured":"Glezer A, Bronstein MD (2014) Prolactinoma. Arq Bras Endocrinol Amp Metabol 58:118\u2013123. https:\/\/doi.org\/10.1590\/0004-2730000002961","journal-title":"Arq Bras Endocrinol Amp Metabol"},{"key":"1964_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41419-019-1526-0","volume":"10","author":"C Tang","year":"2019","unstructured":"Tang C, Sun R, Wen G et al (2019) Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK\/EGR1 and AKT\/mTOR pathway respectively. Cell Death Dis 10:335. https:\/\/doi.org\/10.1038\/s41419-019-1526-0","journal-title":"Cell Death Dis"},{"key":"1964_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","volume":"98","author":"S Mishra","year":"2016","unstructured":"Mishra S, Yadav T, Rani V (2016) Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol 98:12\u201323. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.10.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"1964_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1515\/bmc-2017-0002","volume":"8","author":"V Armand-Labit","year":"2017","unstructured":"Armand-Labit V, Pradines A (2017) Circulating cell-free microRNAs as clinical cancer biomarkers. Biomol Concepts 8:61\u201381. https:\/\/doi.org\/10.1515\/bmc-2017-0002","journal-title":"Biomol Concepts"},{"key":"1964_CR38","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7173","author":"Z Wang","year":"2019","unstructured":"Wang Z, Gao L, Guo X et al (2019) Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2019.7173","journal-title":"Oncol Rep"},{"key":"1964_CR39","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.18632\/oncotarget.23713","volume":"9","author":"V Bernard","year":"2018","unstructured":"Bernard V, Villa C, Auguste A et al (2018) Natural and molecular history of prolactinoma: insights from aPrlr-\/\u2013 mouse model. Oncotarget 9:6144\u20136155. https:\/\/doi.org\/10.18632\/oncotarget.23713","journal-title":"Oncotarget"},{"key":"1964_CR40","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3389\/fendo.2019.00854","volume":"10","author":"T Cheng","year":"2019","unstructured":"Cheng T, Wang Y, Lu M et al (2019) Quantitative analysis of proteome in non-functional pituitary adenomas: clinical relevance and potential benefits for the patients. Front Endocrinol 10:854. https:\/\/doi.org\/10.3389\/fendo.2019.00854","journal-title":"Front Endocrinol"},{"key":"1964_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1677\/erc.1.00949","volume":"12","author":"M Musat","year":"2005","unstructured":"Musat M (2005) Enhanced protein kinase B\/Akt signalling in pituitary tumours. Endocr Relat Cancer 12:423\u2013433. https:\/\/doi.org\/10.1677\/erc.1.00949","journal-title":"Endocr Relat Cancer"},{"key":"1964_CR42","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/hmg\/ddy396","volume":"28","author":"CM Gorvin","year":"2019","unstructured":"Gorvin CM, Newey PJ, Rogers A et al (2019) Association of prolactin receptor (PRLR) variants with prolactinomas. Hum Mol Genet 28:1023\u20131037. https:\/\/doi.org\/10.1093\/hmg\/ddy396","journal-title":"Hum Mol Genet"},{"key":"1964_CR43","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1677\/ERC-09-0101","volume":"16","author":"D Dworakowska","year":"2009","unstructured":"Dworakowska D, Wlodek E, Leontiou CA et al (2009) Activation of RAF\/MEK\/ERK and PI3K\/AKT\/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer 16:1329\u20131338. https:\/\/doi.org\/10.1677\/ERC-09-0101","journal-title":"Endocr Relat Cancer"},{"key":"1964_CR44","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"SR Datta","year":"1999","unstructured":"Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Amp Dev 13:2905\u20132927. https:\/\/doi.org\/10.1101\/gad.13.22.2905","journal-title":"Genes Amp Dev"},{"issue":"9","key":"1964_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.18632\/aging.100202","volume":"2","author":"L Galluzzi","year":"2010","unstructured":"Galluzzi L, Kepp O, Kroemer G (2010) TP53 and MTOR crosstalk to regulate cellular senescence. Aging 2(9):535\u2013537. https:\/\/doi.org\/10.18632\/aging.100202","journal-title":"Aging"},{"key":"1964_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/09168451.2020.1715780","volume":"84","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhao J, Zhang C et al (2020) MiR-219a-2-3p suppresses cell proliferation and promotes apoptosis by targeting MDM2\/p53 in pituitary adenomas cells. Biosci Biotechnol Biochem 84:911\u2013918. https:\/\/doi.org\/10.1080\/09168451.2020.1715780","journal-title":"Biosci Biotechnol Biochem"},{"key":"1964_CR47","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-017-0053-8","volume":"25","author":"M Luo","year":"2018","unstructured":"Luo M, Wu L, Zhang K et al (2018) miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. Cell Death Amp Differ 25:1457\u20131472. https:\/\/doi.org\/10.1038\/s41418-017-0053-8","journal-title":"Cell Death Amp Differ"},{"key":"1964_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/ejh.13276","volume":"103","author":"Y Huang","year":"2019","unstructured":"Huang Y, Zou Y, Zheng R, Ma X (2019) MiR-137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B. Eur J Haematol 103:215\u2013224. https:\/\/doi.org\/10.1111\/ejh.13276","journal-title":"Eur J Haematol"},{"key":"1964_CR49","first-page":"1557","volume":"12","author":"J Duan","year":"2019","unstructured":"Duan J, Lu G, Li Y et al (2019) miR-137 functions as a tumor suppressor gene in pituitary adenoma by targeting AKT2. Int J Clin Exp Pathol 12:1557\u20131564","journal-title":"Int J Clin Exp Pathol"},{"key":"1964_CR50","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.omtn.2020.06.028","volume":"21","author":"Y Wang","year":"2020","unstructured":"Wang Y, Chen R, Zhou X et al (2020) miR-137: a novel therapeutic target for human glioma. Mol Ther Nucleic Acids 21:614\u2013622. https:\/\/doi.org\/10.1016\/j.omtn.2020.06.028","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01964-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01964-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01964-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:57:14Z","timestamp":1684209434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01964-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01964-7","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"3 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors disclosed no relevant relationships.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not involve ethical issues such as conducting clinical trials or animal experiments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}